Vaccination

FDA experts weigh authorizing Novavax COVID-19 vaccine in US

A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax COVID-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine ...

Vaccination

Vaccine hesitancy hardens in richer countries

Governments and health workers in the seven richest nations will find it harder to vaccinate more people against COVID because those yet to have the jab just don't want it, research shows.

Vaccination

Study finds rising, then declining trend in vaccine hesitancy

Since the outbreak of COVID-19 pandemic in early 2020, Hong Kong has recorded a total of 9,000 COVID deaths and more than one million infections in more than two years. In an effort to fight against the pandemic, the government ...

Health

Study identifies factors that shape vaccine preferences

A study involving hypothetical COVID-19 vaccines suggests that vaccine effectiveness and risk of side effects significantly influence people's preferences for one vaccine over another, and that differences between vaccines ...

page 7 from 25